Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Healthcare And Biotech Stocks Continue Their Slide
December 30, 2024
Tickers
ABBV
GILD
IBB
REGN
Tags
Stocks / Equities
Pharma/Biotech
ETFs
From
TalkMarkets
Are You Ready To Trade Biotech Stocks At The Cusp Of A Bear Market?
December 23, 2024
Tickers
ARKG
LLY
MRK
NVAX
Tags
Healthcare
ETFs
Market News
From
TalkMarkets
Top Biotech Short Squeeze Stocks
December 12, 2024
Tickers
CRVO
MTEM
PHAT
SAVA
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
It’s Been A Tough Month For Healthcare Stocks
December 02, 2024
Tickers
ABBV
IHI
LLY
REGN
Tags
Healthcare
ETFs
Market News
From
TalkMarkets
Momentum Model For Trading SMID Biotech Stocks: Broad Rally Underway
November 25, 2024
Tickers
ARKG
IBB
IWM
XBI
Tags
Market News
ETFs
Healthcare
From
TalkMarkets
What To Do After The Worst Week For Healthcare Stocks Since March 2020?
November 19, 2024
Tickers
ABBV
ABT
LLY
XBI
Tags
Pharma/Biotech
Stocks / Equities
Healthcare
From
TalkMarkets
Not-So-Big Pharma
November 16, 2024
Tickers
AZN
BMY
LLY
MRK
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Cidara Therapeutics' Unique Cloudbreak Platform And Its Promise In Influenza And Oncology
November 14, 2024
Tickers
CDTX
CMXHF
JNJ
RHHBY
Tags
Stocks / Equities
Pharma/Biotech
Healthcare
From
TalkMarkets
What Does the Economic Modern Family Say Now?
November 10, 2024
Tickers
BITCOMP
IBB
IHI
IWM
Tags
Market News
Financial
Consumer Goods
From
TalkMarkets
Volatility Hits Large Cap Biopharma: Active Rebalancing May Be Required
November 04, 2024
Tickers
AZN
GILD
LLY
PFE
Tags
ETFs
Healthcare
Market News
From
TalkMarkets
Biotech Momentum Trades For The Q4 Rally
October 29, 2024
Tickers
ABBV
CPRX
CRMD
EXEL
Tags
Market News
Healthcare
Pharma/Biotech
From
TalkMarkets
Healthcare Sector Update: Life in the Slow Lane while we wait for BIOTECH Bounce
October 14, 2024
Tickers
ABT
IBB
JNJ
LLY
Tags
Market News
Healthcare
ETFs
From
TalkMarkets
Biotech Stocks Poised For Another Big Move In Q4
October 07, 2024
Tickers
ABBV
ARKG
CVS
GILD
Tags
Healthcare
ETFs
Market News
From
TalkMarkets
Novo
October 06, 2024
Tickers
NVO
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Week In Review: Regor Sells Two CDK Inhibitors To Genentech For $850 Million
October 05, 2024
Tickers
RHHBY
Tags
Market News
Pharma/Biotech
From
TalkMarkets
Biotech Stocks : Are You A Trader Or A Longer Term Investor?
October 01, 2024
Tickers
ARGX
CRMD
IBB
IMTX
Tags
Healthcare
Market News
Stocks / Equities
From
TalkMarkets
Week In Review: Zenas Raises $259 Million In IPO
September 28, 2024
Tickers
AZN
BAYRY
IMAB
SNY
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
A Biotech Breakout Will Be Led By Small Caps
September 23, 2024
Tickers
ADPT
CPRX
DNLI
NTRA
Tags
Market News
Healthcare
Pharma/Biotech
From
TalkMarkets
The Momentum Is Building, The Markets Are Strong - Just Don’t Chase After Extended Winners
September 22, 2024
Tickers
COST
QQQ
XBI
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Week In Review: Nippon Shinyaku Signs $735 Million Deal For DMD Therapy
September 21, 2024
Tickers
CAPR
NPPNY
OGN
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Beyond QQQ: Two Nasdaq ETFs For Finding Potential Future Tech Superstars
September 20, 2024
Tickers
AMSC
NTAP
QQQJ
QQQS
Tags
Stocks / Equities
Pharma/Biotech
Technology
From
TalkMarkets
Current Report: Bristol-Meyers Squibb (BMY)
September 16, 2024
Tickers
BMY
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Psychedelic Drug Stocks +6% Last Week Vs. -13% Previous Week
September 15, 2024
Tickers
ATAI
CMPS
GHRS
MNMD
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
AI-Focused Drug Discovery Stocks +6% Last Week Vs. -8% Previous Week
September 15, 2024
Tickers
ABCL
ABSI
EXAI
RLAY
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Cloud Stocks: Salesforce Preps To Enter Veeva’s Territory
September 14, 2024
Tickers
CRM
IQV
VEEV
Tags
Technology
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Time To Invest And Or Trade In Bio-Tech Stocks?
September 13, 2024
Tickers
ABBV
AMGN
AZN
BMY
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
AI-Focused Drug Discovery Stocks Portfolio -8% W/e Sept 6th
September 10, 2024
Tickers
ABCL
ABSI
EXAI
RLAY
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Psychedelic Compound-Based Drug Stocks Portfolio -13% W/e Sept. 6th
September 10, 2024
Tickers
ATAI
CMPS
GHRS
MNMD
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Growth At Any Price (GAAP) Is A Bad Strategy. Valuation Matters.
September 08, 2024
Tickers
ALL
AMGN
BIPC
BSX
Tags
Energy
Financial
Consumer Goods
From
TalkMarkets
Week In Review: EpimAb Sells T-Cell Engager In $635 Million Deal
September 07, 2024
Tickers
CNTB
SMHGF
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.